Close Window

Digital Look Email A Friend

Eli Lilly spends nearly $4bn to beef up infectious diseases portfolio

Published by Benjamin Chiou on 26th May 2026

(Sharecast News) - American pharma giant. Eli Lilly and Co on Tuesday announced three acquisitions to beef up its infectious diseases portfolio, spending a combined $3.83bn to buy Curevo, LimmaTech Biologics and Vaccine Company.

URL: http://www.digitallook.com/dl/news/story/35956186/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.